{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:43:05Z","timestamp":1793835785349,"version":"4.6.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2569-4","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T13:35:55Z","timestamp":1499348155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore"],"prefix":"10.1186","volume":"17","author":[{"given":"Monica","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Kheong","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"issue":"3","key":"2569_CR1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1542\/peds.54.3.358","volume":"54","author":"RW Rucker","year":"1974","unstructured":"Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974;54(3):358\u201360.","journal-title":"Pediatrics"},{"issue":"5","key":"2569_CR2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/jac\/dks003","volume":"67","author":"AL Chapman","year":"2012","unstructured":"Chapman AL, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012;67(5):1053\u201362.","journal-title":"J Antimicrob Chemother"},{"key":"2569_CR3","doi-asserted-by":"crossref","unstructured":"Tice, A., Outpatient parenteral antimicrobial therapy (OPAT): a global perspective. Introduction. Chemotherapy, 2001. 47 Suppl 1: p. 1\u20134.","DOI":"10.1159\/000048562"},{"issue":"1","key":"2569_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijantimicag.2013.09.006","volume":"43","author":"M MacKenzie","year":"2014","unstructured":"MacKenzie M, Rae N, Nathwani D. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. Int J Antimicrob Agents. 2014;43(1):7\u201316.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"2569_CR5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2012.01.016","volume":"39","author":"DA Barr","year":"2012","unstructured":"Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents. 2012;39(5):407\u201313.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"2569_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijantimicag.2013.01.015","volume":"41","author":"T Seetoh","year":"2013","unstructured":"Seetoh T, et al. An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort. Int J Antimicrob Agents. 2013;41(6):569\u201373.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"2569_CR7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1086\/340056","volume":"34","author":"ML Grayson","year":"2002","unstructured":"Grayson ML, et al. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults. Clin Infect Dis. 2002;34(11):1440\u20138.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2569_CR8","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkg466","volume":"52","author":"LJ Eron","year":"2003","unstructured":"Eron LJ, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;52(Suppl 1):i3\u201317.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2569_CR9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijantimicag.2011.05.008","volume":"38","author":"RA Seaton","year":"2011","unstructured":"Seaton RA, et al. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents. 2011;38(3):243\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"2569_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1053\/ajem.2001.28330","volume":"19","author":"SL Dong","year":"2001","unstructured":"Dong SL, et al. ED management of cellulitis: a review of five urban centers. Am J Emerg Med. 2001;19(7):535\u201340.","journal-title":"Am J Emerg Med"},{"issue":"7483","key":"2569_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bmj.38309.447975.EB","volume":"330","author":"P Corwin","year":"2005","unstructured":"Corwin P, et al. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ. 2005;330(7483):129.","journal-title":"BMJ"},{"issue":"10","key":"2569_CR12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/emj.2004.018143","volume":"22","author":"M Donald","year":"2005","unstructured":"Donald M, et al. Emergency department management of home intravenous antibiotic therapy for cellulitis. Emerg Med J. 2005;22(10):715\u20137.","journal-title":"Emerg Med J"},{"issue":"12","key":"2569_CR13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/420939","volume":"38","author":"AD Tice","year":"2004","unstructured":"Tice AD, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38(12):1651\u201372.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2569_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000048564","volume":"47","author":"D Nathwani","year":"2001","unstructured":"Nathwani D. The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom. Chemotherapy. 2001;47(Suppl 1):17\u201323.","journal-title":"Chemotherapy"},{"issue":"3","key":"2569_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10096-009-0855-9","volume":"29","author":"PJ Lillie","year":"2010","unstructured":"Lillie PJ, et al. Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting. Eur J Clin Microbiol Infect Dis. 2010;29(3):347\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"2569_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1742-6723.2012.01553.x","volume":"24","author":"T Garrett","year":"2012","unstructured":"Garrett T, et al. Once or twice-daily, algorithm-based intravenous cephazolin for home-based cellulitis treatment. Emerg Med Australas. 2012;24(4):383\u201392.","journal-title":"Emerg Med Australas"},{"issue":"2","key":"2569_CR17","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10\u201352.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2569_CR18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.47102\/annals-acadmedsg.V35N7p479","volume":"35","author":"L Wijaya","year":"2006","unstructured":"Wijaya L, Hsu LY, Kurup A. Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation. Ann Acad Med Singap. 2006;35(7):479\u201386.","journal-title":"Ann Acad Med Singap"},{"issue":"4","key":"2569_CR19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s15010-013-0477-0","volume":"41","author":"SA Winans","year":"2013","unstructured":"Winans SA, Luce AM, Hasbun R. Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone. Infection. 2013;41(4):769\u201374.","journal-title":"Infection"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2569-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T09:51:25Z","timestamp":1692870685000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2569-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2569"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2569-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]},"article-number":"474"}}